Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,851-1,875 of 2,022
CompletedNCT02404194

Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis

This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
United States
Sponsor
Rush University Medical Center
Condition
Schizophrenia
TerminatedNCT00591318

A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis

This study exists to see whether the medication IV can play a useful role in care. Researchers are trying to understand whether the medication IV can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Research Foundation for Mental Hygiene, Inc.
Condition
Schizophrenia
CompletedNCT03504579

Rt-fMRI Neurofeedback and AH in Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Harvard Medical School (HMS and HSDM)
Condition
Schizophrenia
CompletedNCT05042050

Attachment-focused iMAgery Therapy for PSychosis (A-iMAPS)

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherOver 16 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
CompletedNCT03129360

Levetiracetam in Early Psychosis

This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT02832401

The Impact of Caffeine on Cognition in Schizophrenia

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
CompletedNCT00845026

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand how people respond to brain scans or other body measurements in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany, Mexico, Russian Federation, United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
CompletedNCT02411526

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Zogenix, Inc.
Condition
Schizophrenia
CompletedNCT05257720

Evaluation of the Role of Neurodegeneration in Schizophrenia

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Istanbul Saglik Bilimleri University
Condition
Schizophrenia
CompletedNCT04094207

Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Egypt
Sponsor
Sadat City University
Condition
Schizophrenia
CompletedNCT02294409

Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

AnxietyOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Anxiety
CompletedNCT01376596

Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

AnxietyOtherFrom 18 Years to 50 Years
Countries
Canada
Sponsor
Douglas Mental Health University Institute
Condition
Anxiety
TerminatedNCT01307800

A Study of LY2140023 in Patients With Schizophrenia

This study exists to compare options and see whether the medication LY2140023 offers something meaningfully different. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Mexico, United States, Russian Federation, Ukraine
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
WithdrawnNCT05338424

Exercise Target Brain Oscillations in Psychosis

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
CompletedNCT05282329

Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia

This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
China
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
CompletedNCT01555697

Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT05556941

Metacognitive Intervention for Individuals With Severe Mental Disorders

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 23 Years to 68 Years
Countries
Global
Sponsor
University of Haifa
Condition
Schizophrenia
CompletedNCT04176835

Oxytocin and Social Decision Making in Schizophrenia

This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Global
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Condition
Schizophrenia
CompletedNCT05115604

Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
David Batalla-Martin
Condition
Schizophrenia
CompletedNCT02006628

A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

This study exists to compare options and see whether the medication GWP42003 offers something meaningfully different. Researchers are trying to understand whether the medication GWP42003 can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Poland, Romania, United Kingdom
Sponsor
Jazz Pharmaceuticals
Condition
Schizophrenia
CompletedNCT04173572

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
TerminatedNCT04103775

Mechanisms of Cognitive Change

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 100 Years
Countries
United States
Sponsor
Colorado State University
Condition
Schizophrenia
TerminatedNCT04742413

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
Angelini Farmacéutica
Condition
Schizophrenia